Latest news
Stifel Nicolaus Reaffirms "Hold" Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeatMarketBeat · Mon, 10 Aug 2026 14:19:54 GMTStifel Nicolaus Sticks to Its Buy Rating for DraftKings (DKNG) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 18:28:00 GMTMicrochip Recovery Accelerates as Analyst Reaffirms Buy Rating and Maintains $120 Price Target - TipRanksTipRanks · Fri, 07 Aug 2026 16:04:15 GMTStifel Nicolaus Reaffirms Their Buy Rating on Forward Air (FWRD) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:02:00 GMTAnalyst Reaffirms Buy on Latham Amid Market Outperformance and Path to Margin Recovery - TipRanksTipRanks · Fri, 07 Aug 2026 02:35:42 GMTStifel Nicolaus Reaffirms Their Buy Rating on IsoEnergy (ISO) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 14:58:00 GMTJefferies Reaffirms Their Hold Rating on Oneok (OKE) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 09:06:00 GMTBarclays Reaffirms Their Buy Rating on ConvaTec (CTEC) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 06:42:00 GMT